Dirk Jaeger
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 56
- Cancer Immunotherapy and Biomarkers 25
- Colorectal Cancer Treatments and Studies 14
- Lung Cancer Research Studies 9
- CAR-T cell therapy research 7
- Peptidase Inhibition and Analysis 6
- Immunology 19
- Immunotherapy and Immune Responses 13
- Immune Cell Function and Interaction 7
- Co-authors
- Niels Halama (20 shared papers)Dung T. Le (12 shared papers)Emiliano Calvo (9 shared papers)Patrick A. Ott (10 shared papers)Filippo de Braud (7 shared papers)Padmanee Sharma (8 shared papers)Joseph W. Kim (6 shared papers)Marina Tschaika (6 shared papers)
- Journals
- Journal of Clinical Oncology (35 papers)Cancer Research (5 papers)PLoS ONE (4 papers)OncoImmunology (3 papers)Oncology (2 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Dirk Jaeger
88 papers receiving 4.3k citations
Dirk Jaeger's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 2.6k
- Immunology 1.0k
- Pulmonary and Respiratory Medicine 896
- Gastroenterology 149
- Cancer Research 386
Countries citing papers authored by Dirk Jaeger
This map shows the geographic impact of Dirk Jaeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Jaeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Jaeger more than expected).
Fields of papers citing papers by Dirk Jaeger
This network shows the impact of papers produced by Dirk Jaeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Jaeger. The network helps show where Dirk Jaeger may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Jaeger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial Hit paper breakdown → | 2016 | 525 |
| 2 | CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer Hit paper breakdown → | 2018 | 482 |
| 3 | 2011 | 337 | |
| 4 | 2007 | 205 | |
| 5 | 2019 | 180 | |
| 6 | 2009 | 180 | |
| 7 | 2004 | 158 | |
| 8 | 2015 | 139 | |
| 9 | 2013 | 132 | |
| 10 | 2017 | 122 | |
| 11 | 2020 | 117 | |
| 12 | 2018 | 112 | |
| 13 | 2011 | 107 | |
| 14 | 2017 | 96 | |
| 15 | 2018 | 88 | |
| 16 | 2022 | 83 | |
| 17 | 2016 | 83 | |
| 18 | 2013 | 79 | |
| 19 | 2016 | 69 | |
| 20 | 2021 | 64 |
About Dirk Jaeger
Dirk Jaeger is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 92 papers that have together received 4.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (25 papers), Colorectal Cancer Treatments and Studies (14 papers), Immunotherapy and Immune Responses (13 papers), Lung Cancer Research Studies (9 papers), Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (7 papers), Neuroendocrine Tumor Research Advances (7 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Oncology (2.6k citations), Immunology (1.0k citations), Pulmonary and Respiratory Medicine (896 citations), Gastroenterology (149 citations) and Cancer Research (386 citations). Dirk Jaeger has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Niels Halama, Dung T. Le, Emiliano Calvo, Patrick A. Ott, Filippo de Braud, Padmanee Sharma, Joseph W. Kim, Marina Tschaika, Inka Zoernig and Johanna C. Bendell. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, PLoS ONE, OncoImmunology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.